NeuMoDx Molecular, Inc. — Form D
NeuMoDx Molecular, Inc. of ANN ARBOR, MI, a company, filed a Form D exempt-offering notice with the SEC on 2018-05-03. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2018-05-03
- Form: D
- Accession: 0001546171-18-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $20.0M
- Investors: 9
- Date of first sale: 2018-04-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-311549
Issuer
- Name: NeuMoDx Molecular, Inc.
- CIK: 0001546171
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 1250 EISENHOWER PLACE, ANN ARBOR, MI, 48108
- Phone: 734-477-0111
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| William Burkoth | Director | Ann Arbor, MI |
| Jan Garfinkle | Director | Maple Grove, MN |
| Edward Michael | Director | Tel Aviv, L3 |
| Nicole Walker | Director | Ann Arbor, MI |
| Jeffrey Williams | Director | Lakewood, CO |
| Sundaresh Brahmasandra | Executive Officer | Ann Arbor, MI |
| Jeffrey Williams | Executive Officer | Lakewood, CO |
Other filings by this issuer (4)
More